OREX
Vanguard Group’s Orexigen Therapeutics, Inc. OREX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-332,895
| Closed | -$429K | – | 4160 |
|
|
2017
Q4 | $429K | Buy |
332,895
+63,288
| +23% | +$81.6K | ﹤0.01% | 3783 |
|
|
2017
Q3 | $572K | Buy |
269,607
+8,793
| +3% | +$18.7K | ﹤0.01% | 3719 |
|
|
2017
Q2 | $756K | Sell |
260,814
-301,517
| -54% | -$874K | ﹤0.01% | 3637 |
|
|
2017
Q1 | $1.93M | Buy |
562,331
+263,474
| +88% | +$906K | ﹤0.01% | 3392 |
|
|
2016
Q4 | $520K | Sell |
298,857
-111,456
| -27% | -$194K | ﹤0.01% | 3727 |
|
|
2016
Q3 | $1.36M | Sell |
410,313
-3,900,224
| -90% | -$13M | ﹤0.01% | 3500 |
|
|
2016
Q2 | $1.85M | Sell |
4,310,537
-3,302,754
| -43% | -$1.42M | ﹤0.01% | 3407 |
|
|
2016
Q1 | $4.28M | Buy |
7,613,291
+1,556,809
| +26% | +$876K | ﹤0.01% | 3048 |
|
|
2015
Q4 | $10.4M | Buy |
6,056,482
+1,457,295
| +32% | +$2.51M | ﹤0.01% | 2614 |
|
|
2015
Q3 | $9.7M | Buy |
4,599,187
+76,418
| +2% | +$161K | ﹤0.01% | 2623 |
|
|
2015
Q2 | $22.4M | Buy |
4,522,769
+734,783
| +19% | +$3.64M | ﹤0.01% | 2303 |
|
|
2015
Q1 | $29.7M | Buy |
3,787,986
+121,981
| +3% | +$955K | ﹤0.01% | 2163 |
|
|
2014
Q4 | $22.2M | Sell |
3,666,005
-68,120
| -2% | -$413K | ﹤0.01% | 2195 |
|
|
2014
Q3 | $15.9M | Buy |
3,734,125
+741,853
| +25% | +$3.16M | ﹤0.01% | 2288 |
|
|
2014
Q2 | $18.5M | Buy |
2,992,272
+35,191
| +1% | +$217K | ﹤0.01% | 2244 |
|
|
2014
Q1 | $19.2M | Buy |
2,957,081
+182,368
| +7% | +$1.19M | ﹤0.01% | 2201 |
|
|
2013
Q4 | $15.6M | Buy |
2,774,713
+239,767
| +9% | +$1.35M | ﹤0.01% | 2261 |
|
|
2013
Q3 | $15.6M | Buy |
2,534,946
+309,850
| +14% | +$1.9M | ﹤0.01% | 2205 |
|
|
2013
Q2 | $13M | Buy |
+2,225,096
| New | +$13M | ﹤0.01% | 2219 |
|